Abstract

Immune senescence, defined as the age-associated dysregulation and dysfunction of the immune system, is characterised by impaired protective immunity and decreased efficacy of vaccines. Recent clinical, epidemiological and immunological studies suggest that Cytomegalovirus (CMV) infection may be associated with accelerated immune senescence, possibly by restricting the naïve T cell repertoire. However, direct evidence whether and how CMV-infection is implicated in immune senescence is still lacking. In this study, we have investigated whether latent mouse CMV (MCMV) infection with or without thymectomy (Tx) alters antiviral immunity of young and aged mice. After infection with lymphocytic choriomeningitis virus (LCMV) or Vaccinia virus, specific antiviral T cell responses were significantly reduced in old, old MCMV-infected and/or Tx mice compared to young mice. Importantly, control of LCMV replication was more profoundly impaired in aged MCMV-infected mice compared to age-matched MCMV-naïve or young mice. In addition, latent MCMV infection was associated with slightly reduced vaccination efficacy in old Tx mice. In contrast to the prevailing hypothesis of a CMV-mediated restriction of the naïve T cell repertoire, we found similar naïve T cell numbers in MCMV-infected and non-infected mice, whereas ageing and Tx clearly reduced the naïve T cell pool. Instead, MCMV-infection expanded the total CD8+ T cell pool by a massive accumulation of effector memory T cells. Based on these results, we propose a new model of increased competition between CMV-specific memory T cells and any ‘de novo’ immune response in aged individuals. In summary, our results directly demonstrate in a mouse model that latent CMV-infection impairs immunity in old age and propagates immune senescence.

Highlights

  • Immune senescence, defined as the age-related alterations of the immune system, is associated with an increased incidence of infections, cancer, autoimmunity and a reduced efficacy of prophylactic vaccines [1,2,3]

  • Recent human studies have suggested that this investment may come at the cost of accelerated immune senescence, a condition describing the age-associated decline of the immune system’s functionality

  • We propose an alternative mechanism of CMV-enhanced immune senescence based on T cell competition between CMV-specific memory T cells and de novo generated T cell responses

Read more

Summary

Introduction

Immune senescence, defined as the age-related alterations of the immune system, is associated with an increased incidence of infections, cancer, autoimmunity and a reduced efficacy of prophylactic vaccines [1,2,3]. Immune senescence is certainly a multifactorial process involving genetic, molecular, cellular and environmental factors. Among the latter, Cytomegalovirus (CMV) infection has gained considerable interest in recent years as a potential propagator of human immune senescence [12]. Protective antibody titres after influenza vaccination were reduced in HCMV-positive compared to HCMV-negative elderly individuals, this finding was not confirmed in a subsequent study [16,17]. Together, these studies suggest that HCMV-infection may be associated with decreased immunocompetence of the elderly.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call